OliX Pharmaceuticals to Conduct One-on-One Meetings with Potential Partners at BIO Digital 2021 Conference

SUWON, Republic of Korea, June 10, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will hold one-on-one partnering meetings at BIO Digital 2021, being held virtually June 14-18, 2021. Sun Woo Hong, Ph.D., head of R&D at OliX Pharmaceuticals, will be available to discuss global licensing options for the Company’s pipeline programs for hepatitis B virus (HBV) and androgenic alopecia (hair

from Yahoo Canada Sports - Sports News, Scores, Rumours, Fantasy Games, and more https://ift.tt/35amQgh
via IFTTT